NO20070592L - Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring. - Google Patents
Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring.Info
- Publication number
- NO20070592L NO20070592L NO20070592A NO20070592A NO20070592L NO 20070592 L NO20070592 L NO 20070592L NO 20070592 A NO20070592 A NO 20070592A NO 20070592 A NO20070592 A NO 20070592A NO 20070592 L NO20070592 L NO 20070592L
- Authority
- NO
- Norway
- Prior art keywords
- amyloid deposition
- diagnosis
- procedure
- diseases associated
- prodromal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Det tilveiebringes en fremgangsmåte til identifikasjon av en pasient som værende i prodromalfasen av en sykdom assosiert med amyloidavleiring ved hjelp av skanningsteknikker. I tillegg tilveiebringes det en fremgangsmåte til identifikasjon av amyloidavleiringssykdommer hos pasienter som utviser en demenslidelse av usikker etiologi ved hjelp av skanningsteknikker. Fremgangsmåtene beskriver stoffer som anvendes til skanning og generering av data som kan anvendes til å bestemme progresjonen av en asymptomatisk pasient til en sykdom assosiert med amyloidavleiring, eller å identifisere amyloidavleiringssykdommer hos pasienter med en demenslidelse av usikker etiologi.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58449504P | 2004-07-02 | 2004-07-02 | |
PCT/US2005/023618 WO2006014382A1 (en) | 2004-07-02 | 2005-07-01 | A method of diagnosing prodromal forms of diseases associated with amyloid deposition |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070592L true NO20070592L (no) | 2007-03-27 |
Family
ID=35058815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070592A NO20070592L (no) | 2004-07-02 | 2007-01-31 | Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20080286202A1 (no) |
EP (1) | EP1768709A1 (no) |
JP (1) | JP2008505116A (no) |
CN (2) | CN101060865B (no) |
AU (1) | AU2005270027A1 (no) |
BR (1) | BRPI0512932A (no) |
CA (1) | CA2587253A1 (no) |
HK (1) | HK1110218A1 (no) |
NO (1) | NO20070592L (no) |
RU (1) | RU2007104106A (no) |
WO (1) | WO2006014382A1 (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2427963T3 (es) | 2004-07-02 | 2013-11-05 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Uso de derivados de tioflavina radiomarcados en formación de imágenes de amiloide para evaluación de las terapias antiamiloide |
EP1937260A2 (en) * | 2005-09-16 | 2008-07-02 | University of Pittsburgh | In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
WO2008118122A2 (en) | 2006-05-08 | 2008-10-02 | Molecular Neuroimaging, Llc | Compounds and amyloid probes thereof for therapeutic and imaging uses |
JP5319121B2 (ja) | 2007-01-30 | 2013-10-16 | 株式会社東芝 | 診療支援システム及び診療支援装置 |
ES2414614T3 (es) * | 2007-01-30 | 2013-07-22 | Ge Healthcare Limited | Herramientas para ayudar en el diagnóstico de enfermedades neurodegenerativas |
US7858803B2 (en) | 2007-04-27 | 2010-12-28 | The General Hospital Corporation | Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders |
BRPI0815129B8 (pt) * | 2007-08-30 | 2021-05-25 | Ge Healthcare Ltd | composição radiofarmacêutica, e, métodos para preparação de uma composição radiofarmacêutica |
JP2011514343A (ja) * | 2008-02-27 | 2011-05-06 | アビッド レディオファーマシューティカルズ、インク. | 放射線標識a−ベータ結合化合物を用いたアミロイドプラークのガンマプローブ検出 |
JP5565647B2 (ja) * | 2008-03-14 | 2014-08-06 | よこはまティーエルオー株式会社 | 臓器領域特定方法、および臓器領域特定装置 |
CA2737028C (en) | 2008-09-23 | 2017-06-27 | Wista Laboratories Ltd. | Ligands for aggregated tau molecules |
JP6026089B2 (ja) * | 2011-08-23 | 2016-11-16 | 東芝メディカルシステムズ株式会社 | 医用画像診断装置、画像情報表示装置及び制御プログラム |
JP6130401B2 (ja) * | 2012-01-20 | 2017-05-17 | アンナプラガダ,アナンス | 医学画像を客観的に特徴付けるための方法および組成物 |
WO2014195448A1 (en) * | 2013-06-07 | 2014-12-11 | Koninklijke Philips N.V. | Amyloid pet brain scan quantification based on cortical profiles |
CN103724207B (zh) * | 2013-12-20 | 2016-07-06 | 北京智博高科生物技术有限公司 | 苯基苄基醚类衍生物及其制备方法和应用 |
GB201511846D0 (en) * | 2015-07-07 | 2015-08-19 | Ge Healthcare Ltd | Beta amyloid staging |
JPWO2017086303A1 (ja) * | 2015-11-16 | 2018-09-20 | キリン株式会社 | ペプチド組成物およびその製造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874431A (en) * | 1993-08-28 | 1999-02-23 | Cancer Research Campaign Technology Limited | Benzazole compounds |
US6410598B1 (en) * | 1994-02-03 | 2002-06-25 | Michael P. Vitek | Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
WO2002016333A2 (en) * | 2000-08-24 | 2002-02-28 | University Of Pittsburgh | Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
US7270800B2 (en) * | 2000-08-24 | 2007-09-18 | University Of Pittsburgh | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
CA2421374C (en) * | 2000-09-06 | 2017-03-07 | Aventis Pharma S.A. | Methods and compositions for diseases associated with amyloidosis |
TWI245764B (en) * | 2001-04-23 | 2005-12-21 | Hank F Kung | Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
CA2474411A1 (en) * | 2002-02-13 | 2003-08-21 | Amersham Plc | Benzothiazole derivatives for in vivo imaging of amyloid plaques |
-
2005
- 2005-07-01 US US11/666,084 patent/US20080286202A1/en not_active Abandoned
- 2005-07-01 JP JP2007519501A patent/JP2008505116A/ja active Pending
- 2005-07-01 EP EP05764066A patent/EP1768709A1/en not_active Ceased
- 2005-07-01 RU RU2007104106/04A patent/RU2007104106A/ru not_active Application Discontinuation
- 2005-07-01 WO PCT/US2005/023618 patent/WO2006014382A1/en active Application Filing
- 2005-07-01 CN CN2005800271888A patent/CN101060865B/zh active Active
- 2005-07-01 CA CA002587253A patent/CA2587253A1/en not_active Abandoned
- 2005-07-01 BR BRPI0512932-0A patent/BRPI0512932A/pt not_active Application Discontinuation
- 2005-07-01 AU AU2005270027A patent/AU2005270027A1/en not_active Abandoned
- 2005-07-01 CN CN2011102510382A patent/CN102327626A/zh active Pending
-
2007
- 2007-01-31 NO NO20070592A patent/NO20070592L/no not_active Application Discontinuation
-
2008
- 2008-04-17 HK HK08104372.2A patent/HK1110218A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2007104106A (ru) | 2008-08-10 |
CN101060865A (zh) | 2007-10-24 |
BRPI0512932A (pt) | 2008-04-15 |
JP2008505116A (ja) | 2008-02-21 |
EP1768709A1 (en) | 2007-04-04 |
US20080286202A1 (en) | 2008-11-20 |
CN101060865B (zh) | 2011-10-05 |
CN102327626A (zh) | 2012-01-25 |
WO2006014382A1 (en) | 2006-02-09 |
AU2005270027A1 (en) | 2006-02-09 |
CA2587253A1 (en) | 2006-02-09 |
HK1110218A1 (en) | 2008-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070592L (no) | Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring. | |
Filibian et al. | In vivo imaging of glia activation using 1H‐magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity | |
Gomar et al. | Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data | |
Chiu et al. | Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer’s disease | |
Petoumenos et al. | Increased risk of cardiovascular disease (CVD) with age in HIV‐positive men: a comparison of the D: A: D CVD risk equation and general population CVD risk equations | |
Cleland et al. | Covert contrast and covert errors in persistent velar fronting | |
Moghekar et al. | Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort | |
CY1110252T1 (el) | Μεθοδος για την προβλεψη, διαγνωση και διαφορικη διαγνωση της νοσου του αλτζχαιμερ | |
WO2008030973A3 (en) | Methods and compositions for the detection of protein folding disorders | |
Connor et al. | The validity of the Brief Michigan Alcohol Screening Test (bMAST) as a problem drinking severity measure | |
Shimomura et al. | Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients | |
Li et al. | Effect of human cerebrospinal fluid sampling frequency on amyloid‐β levels | |
Haghshomar et al. | White matter changes correlates of peripheral neuroinflammation in patients with Parkinson’s disease | |
WO2014052921A3 (en) | Patient health record similarity measure | |
MX2022001817A (es) | Metodos para detectar isoformas de la region de union a microtubulos (mtbr) tau y uso de las mismas. | |
Sun et al. | Normal reference values of diastolic strain rate in healthy individuals: chronological trends and the comparison according to genders | |
Kovács et al. | Genetically determined pattern of left ventricular function in normal and hypertensive hearts | |
Mirzakhanian et al. | Biomarkers in psychosis: an approach to early identification and individualized treatment | |
Cabrera et al. | Spironolactone increases serum uric acid levels in patients with chronic kidney disease | |
Griffo et al. | Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design | |
Aggarwal et al. | Hypertrophic cardiomyopathy associated with sleep apnea: serious implications and COGENT management strategy | |
WO2009079977A3 (de) | Verfahren zur schlafmedizinischen vorabdiagnose und therapie-begleitung | |
Javed et al. | Using limb-lead ECGs to investigate asymptomatic atrial fibrillation in primary care | |
RU2018105982A (ru) | Способ дифференциальной диагностики форм хронического тонзиллита с использованием раман-флюоресцентной спектроскопии | |
Mohd Hadi Pritam | Facial creases in human identification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |